BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join
back to Directory

Allcyte (acquired by Exscientia)

Allcyte logo

Website
https://www.allcyte.com/
Founded
2017
Publications
5

Technologies

AI Companies (Drug Discovery)

Allcyte is a biotech start-up focused on precision medicine and drug development in a patient-centric way using high-content imaging and AI. Allcyte is now be part of Exscientia

health diagnostics

#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

 

R&D Platform

With our Pharmacoscopy® platform, we generate actionable insights into the functional activity of drugs and drug candidates directly in viable, primary tissue samples of human cancer patients at the single cell level.

Leverage Pharmacoscopy® to enhance the patient relevance of drug discovery and preclinical research across all R&D phases to ultimately increase the chances of success in clinical development.

Learn how Pharmacoscopy® can be used to improve patient response through ex vivo drug screening in primary tumour tissues. Explore big data applications that can drive genetic biomarker and target discovery in oncology.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.